FOR ACUTE BLEEDING PATIENTS
Your Lab is Integral to FAST, EASY, and RELIABLE Targeted Therapy
With the broadest indications for a cartridge-based whole blood hemostasis analyzer(1), Quantra® Hemostasis System may be the platform your lab needs.
"*" indicates required fields
Now FDA-approved for the following viscoelastic testing (VET) indications:
- Cardiac Surgery
- Trauma
- Liver Transplantation
- Major Orthopedic Surgery
IN ACUTE BLEEDING SITUATIONS, EVERY SECOND MATTERS
The Quantra® System quickly delivers results enabling you to make decisions FAST
- Complete QPlus® cartridge results typically in ~12.5 minutes(2)
- Complete QStat® cartridge lysis results on average in 44 ± 10 minutes(3)
- Hands-on time of <1 minute with no pipetting(1)
In a fast-paced environment, you need a device that is easy to operate, quick to learn, and integrates into your existing structure.
The Quantra Hemostasis System:
- Is an easy to operate, fully automated system with an intuitive dials display(1-3)
- Is quick to learn-after a short 30-minute training, new users were able to read and interpret the results with 95% proficiency(4,5)
- Has a light IT footprint that integrates into the existing laboratory and POC IT infrastructure(6)
- Uses cartridges which are stored at room temperature - no refrigeration needed
- Offers intuitive user and QC management with lockout features
The Quantra Hemostasis System fits seamlessly into the workflow of your lab and requires minimal time to train your personnel
Indications: The Quantra Hemostasis System is comprised of the Quantra Hemostasis Analyzer, QPlus Cartridge, QStat Cartridge, Quantra Quality Controls (Level 1 and Level 2), Quantra Cleaning Cartridge, and Quantra Desktop Remote Viewer (QDRV) Software. The QPlus Cartridge is indicated for the evaluation of blood coagulation in perioperative patients age 18 years and older to assess possible hypocoagulable and hypercoagulable conditions in cardiovascular or major orthopedic surgeries before, during, and following the procedure. The QStat Cartridge is indicated for the evaluation of blood coagulation and clot lysis in patients age 18 years and older to assess possible hypocoagulable and hypercoagulable conditions in trauma and liver transplantation procedures.
Results obtained with the Quantra System should not be the sole basis for patient diagnosis.Rx Only.
References: 1. Quantra® Hemostasis Analyzer User Manual. 2020. HemoSonics, LLC. 2. QPlus Cartridge Instructions for Use (IFU). HemoSonics, LLC. 3. QStat Cartridge Instructions for Use (IFU). HemoSonics, LLC. 4. Winegar DA, Viola F. Is the Quantra QPlus system easy to interpret? American Association of Clinical Chemistry (AACC) Annual Scientific Meeting, Virtual Congress, December 13-17, 2020. 5. Winegar DA, Gillespie C, Sanchez-Illan M. Improving the interpretation of viscoelastic test results in the critical care setting. American Association of Clinical Chemistry (AACC) Annual Scientific Meeting, July 24-28, 2022. 6. Quantra System IT and Networking Guide. HemoSonics, LLC.
©2023 HemoSonics, LLC. All rights reserved. XXX-XXX-XXX